Recent News
Chronic inflammatory bowel diseases: Predicting the success of biologicals
An international team led by researchers from the Institute of Clinical Molecular Biology (IKMB) has found biomarkers that indicate at the beginning of anti-TNF alpha therapy whether it will be effective.
With chronic inflammatory bowel …read more
Report on 1st PhD Conference of CRC 1371 & DFG Research Unit miTarget 5042
“From North to South – Microbiome connects”
We were not only surprised but also highly excited when doctoral students from CRC 1371 of Technical University of Munich (TUM) invited us for a “PhD/Postdoc only” conference …read more
Berchtesgaden Microbiome Science Days 2022
Microbiome Summit Meeting in the Alps
Once again, with the strong participation of the IKMB, the 6th annual symposium Berchtesgaden Microbiome Science Days (BMSD) took place.
The role of the microbiome in complex chronic diseases …read more
Large-scale study finds ten new risk genes for Crohn’s disease
The results of the international study point to a previously unknown process in the development of this chronic inflammatory bowel disease.
The special features of the study are its size as well as its methodological …read more
Training in molecular cloning at the University of Lübeck
An experience report by Aya Mahdy, doctoral researcher at the Institute of Clinical Molecular Biology
I am currently working on phage immunoprecipitation sequencing’ (PhIP-Seq) for high-throughput immunological fingerprinting in inflammatory bowel diseases to develop a …read more
Report on DAAD Rise Scholarship Summer 2022
Internship: Investigating the functional potential of single bacterial isolates in the context of inflammatory bowel disease: Broad insights into the phenotypical characterisation of the beneficial gut bacterium B. longum
I applied for the DAAD Rise …read more
